Cornerstone Therapeutics (CRTX) Beats Q1 Views
Tweet
Share
E-mailGet Alerts CRTX Hot Sheet
Price: $1.95 --0%
Financial Fact:
Total costs and expenses: 37.66M
Today's EPS Names:
NLY, CP, RUSHA, More
Financial Fact:
Total costs and expenses: 37.66M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Cornerstone Therapeutics Inc. (NASDAQ: CRTX) reported Q1 EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $29.98 million versus the consensus estimate of $29.63 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Tops Q1 EPS by 20c; offers guidance
- National Capital Bancorp, Inc. (NACB) Reports Q1 Revenue
- CVB Financial (CVBF) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
